Search Results - "van de Putte, L B"

Refine Results
  1. 1

    Homocysteine and folate status in methotrexate‐treated patients with rheumatoid arthritis by van Ede, A. E., Laan, R. F. J. M., Blom, H. J., Boers, G. H. J., Haagsma, C. J., Thomas, C. M. G., de Boo, T. M., van de Putte, L. B. A.

    Published in Rheumatology (Oxford, England) (01-06-2002)
    “…Objective. To study (i) the influence of methotrexate (MTX) therapy on homocysteine and folate metabolism in patients with rheumatoid arthritis (RA), (ii) the…”
    Get full text
    Journal Article
  2. 2

    Diffuse and localized pigmented villonodular synovitis : evaluation of treatment of 38 patients by DE VISSER, E, VETH, R. P. H, PRUSZCZYNSKI, M, WOBBES, T, VAN DE PUTTE, L. B. A

    Published in Archives of orthopaedic and trauma surgery (01-11-1999)
    “…We performed a retrospective study of 38 patients with pigmented villonodular synovitis (PVNS) to evaluate the treatment and functional results. The mean age…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine by Scott, D L, Smolen, J S, Kalden, J R, van de Putte, L B A, Larsen, A, Kvien, T K, Schattenkirchner, M, Nash, P, Oed, C, Loew-Friedrich, I

    Published in Annals of the rheumatic diseases (01-10-2001)
    “…OBJECTIVE Recent studies have demonstrated the short term efficacy of leflunomide. This study evaluates the efficacy and safety of leflunomide and…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The synergistic value of focus score and IgA% score of sublabial salivary gland biopsy for the accuracy of the diagnosis of Sjögren's syndrome: A 10-year comparison by ZANDBELT, M. M, WENTINK, J. R. M, DE WILDE, P. C. M, VAN DAMME, P. A, VAN DE PUTTE, L. B. A, VAN DEN HOOGEN, F. H. J

    Published in Rheumatology (Oxford, England) (01-07-2002)
    “…Increasing the accuracy of the diagnosis of Sjögren's syndrome (SS) by placing emphasis on objective findings such as the presence of anti-Ro and anti-La…”
    Get full text
    Journal Article
  7. 7

    No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset by Kroot, E J A, van Leeuwen, M A, van Rijswijk, M H, Prevoo, M L L, Van 't Hof, M A, van de Putte, L B A, van Riel, P L C M

    Published in Annals of the rheumatic diseases (01-12-2000)
    “…OBJECTIVE To investigate mortality, functional capacity, and prognostic factors for mortality in an inception cohort of patients with recently diagnosed RA…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints by van der Kraan, PM, Vitters, EL, van de Putte, LB, van den Berg, WB

    Published in The American journal of pathology (01-12-1989)
    “…Male, 10-week-old C57B1 10 mice received a single intraarticular injection in the knee joints with papain, iodoacetate, or collagenase. This led to…”
    Get full text
    Journal Article
  10. 10

    Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score by van der Heijde, D M, van 't Hof, M A, van Riel, P L, Theunisse, L A, Lubberts, E W, van Leeuwen, M A, van Rijswijk, M H, van de Putte, L B

    Published in Annals of the rheumatic diseases (01-11-1990)
    “…An investigation of clinical and laboratory variables which might form the basis for judging disease activity in clinical practice was made by six…”
    Get full text
    Journal Article
  11. 11

    Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies by Schellekens, G A, de Jong, B A, van den Hoogen, F H, van de Putte, L B, van Venrooij, W J

    Published in The Journal of clinical investigation (01-01-1998)
    “…Only a few autoantibodies that are more or less specific for RA have been described so far. The rheumatoid factor most often tested for is not very specific…”
    Get full text
    Journal Article
  12. 12

    Septic arthritis with Listeria monocytogenes during low‐dose methotrexate by Jansen, T. L. Th. A., Van Heereveld, H. A. E. M., Laan, R. F. L. M., Barrera, P., Van De Putte, L. B. A.

    Published in Journal of internal medicine (01-07-1998)
    “…Jansen TLThA, van Heereveld HAEM, Laan RFLM, Barrera P, van de Putte LBA (University Hospital Nijmegen, Nijmegen, The Netherlands). Septic arthritis with…”
    Get full text
    Journal Article
  13. 13

    Drug survival, efficacy and toxicity of monotherapy with a fully human anti‐tumour necrosis factor‐α antibody compared with methotrexate in long‐standing rheumatoid arthritis by Barrera, P., van der Maas, A., van Ede, A. E., Kiemeney, B. A. L. M., Laan, R. F. J. M., van de Putte, L. B. A., van Riel, P. L. C. M.

    Published in Rheumatology (Oxford, England) (01-04-2002)
    “…Objectives. To compare the 48‐week drug survival, efficacy and toxicity of monotherapy with a fully human anti‐tumour necrosis factor‐α (TNF‐α) monoclonal…”
    Get full text
    Journal Article
  14. 14

    Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system by Creemers, M C W, Franssen, M J A M, van ’t Hof, M A, Gribnau, F W J, van de Putte, L B A, van Riel, P L C M

    Published in Annals of the rheumatic diseases (01-01-2005)
    “…Objective: To develop and validate an extensive radiographic scoring system for ankylosing spondylitis (AS). Methods: The Stoke Ankylosing Spondylitis Spinal…”
    Get full text
    Journal Article
  15. 15

    Radiolabelled interleukin‐1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis by Barrera, P., van der Laken, C. J., Boerman, O. C., Oyen, W. J. G., van de Ven, M. T. P., van Lent, P. L. E. M., van de Putte, L. B. A., Corstens, F. H. M.

    Published in Rheumatology (Oxford, England) (01-08-2000)
    “…Objectives. To investigate the distribution of radiolabelled interleukin‐1 receptor antagonist (IL‐1ra) in patients with rheumatoid arthritis (RA) and to…”
    Get full text
    Journal Article
  16. 16

    In vivo role of phagocytic synovial lining cells in onset of experimental arthritis by Van Lent, PL, Van den Hoek, AE, Van den Bersselaar, LA, Spanjaards, MF, Van Rooijen, N, Dijkstra, CD, Van de Putte, LB, Van den Berg, WB

    Published in The American journal of pathology (01-10-1993)
    “…The in vivo role of phagocytic synovial lining cells (SLC) was studied in acute experimental arthritis in the mouse. SLCs were selectively depleted by…”
    Get full text
    Journal Article
  17. 17

    Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis by van der Heijde, D M, van't Hof, M A, van Riel, P L, van Leeuwen, M A, van Rijswijk, M H, van de Putte, L B

    Published in Annals of the rheumatic diseases (01-02-1992)
    “…There is no agreement as to which variable best mirrors disease activity in rheumatoid arthritis (RA) and no studies have been performed on the validity of…”
    Get full text
    Journal Article
  18. 18

    Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients by Rodenburg, Richard J T, van den Hoogen, Frank H J, Barrera, Pilar, van Venrooij, Walther J, van de Putte, Leo B A

    Published in Annals of the rheumatic diseases (01-10-1999)
    “…OBJECTIVE Synovial inflammation in patients with rheumatoid arthritis (RA) is characterised by the presence of large numbers of highly activated monocytes and…”
    Get full text
    Journal Article
  19. 19

    Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren's syndrome by Zandbelt, M M, van den Hoogen, F H J, de Wilde, P C, van den Berg, P J S, Schneider, H G F, van de Putte, L B A

    Published in Annals of the rheumatic diseases (01-05-2001)
    “…Sjögren's syndrome (SS) is a chronic autoimmune disease characterised by specific lesions in exocrine glands, so sublabial minor salivary gland biopsy (SLGB)…”
    Get full text
    Journal Article
  20. 20

    Methotrexate-related pulmonary complications in rheumatoid arthritis by Barrera, P, Laan, R F, van Riel, P L, Dekhuijzen, P N, Boerbooms, A M, van de Putte, L B

    Published in Annals of the rheumatic diseases (01-07-1994)
    “…Methotrexate (MTX) was described as a drug in 1946 and first used in the treatment of human disease (childhood leukaemia) in 1948. Successful MTX treatment for…”
    Get full text
    Journal Article